4
Participants
Start Date
January 3, 2023
Primary Completion Date
October 14, 2024
Study Completion Date
December 11, 2024
Imipenem/Cilastatin/Relebactam
Patients will receive intravenous imipenem/cilastatin/relebactam every 6 hours for 10-14 days.
University of Pittsburgh Medical Center, Pittsburgh
Children's Hospital Los Angeles, Los Angeles
Hartford Hospital, Hartford
Collaborators (1)
Merck Sharp & Dohme LLC
INDUSTRY
Q2 Solutions
INDUSTRY
Connecticut Children's Medical Center
OTHER
St. Christopher's Hospital for Children
OTHER
University of Texas Southwestern Medical Center
OTHER
University of Pittsburgh Medical Center
OTHER
Indiana University Health Methodist Hospital
OTHER
James Whitcomb Riley Hospital for Children
OTHER
Hartford Hospital
OTHER